The study participants already had blood levels within the target range at the beginning of the study and blood levels of subjects in the intervention groups and control / placebo were similar because of the great individual variability in the cogniflex response rate of omega-3 dietary supplements. For clearer results, future intervention studies should recruit participants with a low initial rate of omega-3 and reach the proposed target range of between 8 and 11% with varying doses. Since it has not carried out any large-scale clinical trial based on the ratio of omega-3, still no direct evidence to extract therapeutic consequences of the index of omega-3. However, several cardio logical and guidelines recommend increased consumption of EPA and DHA in cardiovascular prevention. Mentioned health problems are increasing over the years worldwide. In 2020, heart disease, depression and cerebrovascular diseases, including dementia, will be among the four most common diseases in the western world. Not so in Japan

http://healthnbeautyfacts.com/cogniflex/